Liberating from Insulin Dependency
Betalin Therapeutics Ltd. is at the forefront of biotechnology research, dedicated to liberating diabetic patients from insulin dependency. With a focus on innovation and patient well-being, Betalin Therapeutics Ltd. is developing a micro-pancreas designed to respond to patients' blood glucose levels, releasing controlled therapeutic levels of insulin for at least 12 months. This groundbreaking technology promises to significantly improve the lives of over 537 million diabetic individuals worldwide.
Located at the Hadassah Ein Karem campus in Jerusalem, Betalin Therapeutics Ltd. specializes in cell therapy, type 1 diabetes solutions, and tissue engineering and regenerative medicine. The company's commitment to cutting-edge research and development positions it as a leader in the biotechnology field, striving to provide long-lasting solutions for diabetes management.
Betalin Therapeutics Ltd. continues to advance its innovative therapies, aiming to transform diabetes care and enhance the quality of life for patients globally. We invite the management team at Betalin Therapeutics Ltd. to create a customized and exclusive company showcase and product listing on our platform to further highlight their pioneering work.
Compare Betalin Therapeutics Ltd. with 1 companies in Biotechnology-Research
| Comparison Field |
Betalin Therapeutics Ltd.Main Company |
SeraxisView Profile |
|---|---|---|
|
Founded Year
|
— | 2013 |
|
Company Size
|
— | 11-50 |
|
City
|
Germantown, Maryland | |
|
Country
|
United States | |
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Biotechnology
Diabetes
Insulin Dependency
Cell Therapy
Regenerative Medicine
Micro-Pancreas
Tissue Engineering
Cell therapy
Type 1 Diabetes
Tissue Engineering & Regenerative Medicine
|
5 Total
5 Unique
Unique Skills:
Functional endocrine pancreas
Off-the-shelf implants
Organ replacement
Regenerative medicine
Stem cells
|
Other organizations in the same industry
This company is also known as